Abbott Laboratories Financial Ratios
NYSE: ABTHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:02 PM ET · Delayed 15 min
Abbott Laboratories ratio analysis
Abbott Laboratories earned a net margin of 14.7% in FY 2025, down from 31.9% a year earlier. Gross margin was 56.4% compared with a median of 56.4% over the prior 9 years. Return on equity reached 12.5%, meaning Abbott Laboratories generated 0.13 dollars of profit for every dollar of shareholders' equity.
Debt-to-equity stood at 0.25 versus 0.30 the year before, and the current ratio was 1.58. At the end of FY 2025, ABT traded at 33.4 times earnings; across the 10 fiscal years shown, its year-end P/E ranged from 14.9 to 211.4, with a median of 38.3. Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.
Summary generated from market data by MetaCap's automated system. Methodology
Abbott Laboratories financial ratios (annual)
| Ratio | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| P/E ratio (at fiscal year end) | 33.38 | 14.90 | 33.76 | 28.08 | 35.72 | 43.80 | 41.69 | 51.21 | 211.37 | 40.86 |
| Price / sales | 4.88 | 4.72 | 4.78 | 4.41 | 5.80 | 5.61 | 4.76 | 3.92 | 3.63 | 2.72 |
| Price / book | 4.15 | 4.16 | 4.96 | 5.25 | 6.98 | 5.92 | 4.88 | 3.92 | 3.21 | 2.76 |
| Gross margin | 56.4% | 55.4% | 55.2% | 56.1% | 57.0% | 56.6% | 58.5% | 58.4% | 54.7% | 56.4% |
| Operating margin | 18.2% | 16.3% | 16.2% | 19.2% | 19.6% | 15.5% | 14.2% | 11.9% | 5.7% | 14.5% |
| Net margin | 14.7% | 31.9% | 14.3% | 15.9% | 16.4% | 13.0% | 11.6% | 7.7% | 1.7% | 6.7% |
| Free cash flow margin | 16.7% | 15.1% | 12.6% | 17.9% | 20.1% | 16.5% | 14.1% | 16.0% | 16.2% | 10.0% |
| Return on equity (ROE) | 12.5% | 28.1% | 14.8% | 18.9% | 19.8% | 13.7% | 11.9% | 7.8% | 1.5% | 6.8% |
| Return on assets (ROA) | 7.5% | 16.5% | 7.8% | 9.3% | 9.4% | 6.2% | 5.4% | 3.5% | 0.6% | 2.7% |
| Debt / equity | 0.25 | 0.30 | 0.38 | 0.46 | 0.50 | 0.57 | 0.58 | 0.64 | 0.90 | 1.07 |
| Current ratio | 1.58 | 1.67 | 1.64 | 1.63 | 1.85 | 1.72 | 1.44 | 1.62 | 2.26 | 4.02 |
| Revenue growth | 5.7% | 4.6% | -8.1% | 1.3% | 24.5% | 8.5% | 4.3% | 11.6% | 31.3% | 2.2% |
| EPS growth | -51.3% | 134.4% | -16.6% | -0.8% | 57.6% | 21.4% | 54.9% | 392.6% | -71.3% | -67.8% |